|
Dec 3 (Reuters) - Moderna Inc said on Thursday it expects to have between 100 million and 125 million doses of its COVID-19 vaccine available globally in the first quarter of 2021. Themuscles of the hindlimb dog company said 85 million to 100 million of those doses would be available in the United States, with 15 million to 25 million outside the country. (Reporting by Dania Nadeem in Bengaluru; Editing by Devika Syamnath)
View comments
|
Managers’ transactions - 1U.S. Should Cut the Swiss Some Slack on Currency ManipulationThe Attractive Combination That Could Earn Allegiance Bancshares, Inc. (NASDAQ:ABTX) A Place In Your Dividend PortfolioEuropean Stocks Seen Higher; U.S. Election in SpotlightModerna to supply 100 to 125 mln COVID-19 vaccine doses globally in first quarterIMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Inovio Pharmaceuticals, Inc. and Encourages Investors with Losses in Excess of $500,000 to Contact the FirmNetCents Technology Notches Record Transaction Volume, AgainDrone Delivery Canada Begins Flights For First Paying CustomerIIOT-OXYS, Provides Business Update on COVID-19Antibodies, Protein-based Vaccines, Anti-virals, and Cell-based Therapies to Lead the Development of COVID-19 Treatment Pipeline- Exclusive Report by Meticulous Research®
